Setting the stage for next-generation risk assessment with non-animal approaches: the EU-ToxRisk project experience

In 2016, the European Commission launched the EU-ToxRisk research project to develop and promote animal-free approaches in toxicology. The 36 partners of this consortium used in vitro and in silico methods in the context of case studies (CSs). These CSs included both compounds with a highly defined target (e.g. mitochondrial respiratory chain inhibitors) as well as compounds with poorly defined molecular initiation events (e.g. short-chain branched carboxylic acids). The initial project focus was on developing a science-based strategy for read-across (RAx) as an animal-free approach in chemical risk assessment. Moreover, seamless incorporation of new approach method (NAM) data into this process (= NAM-enhanced RAx) was explored. Here, the EU-ToxRisk consortium has collated its scientific and regulatory learnings from this particular project objective. For all CSs, a mechanistic hypothesis (in the form of an adverse outcome pathway) guided the safety evaluation. ADME data were generated from NAMs and used for comprehensive physiological-based kinetic modelling. Quality assurance and data management were optimized in parallel. Scientific and Regulatory Advisory Boards played a vital role in assessing the practical applicability of the new approaches. In a next step, external stakeholders evaluated the usefulness of NAMs in the context of RAx CSs for regulatory acceptance. For instance, the CSs were included in the OECD CS portfolio for the Integrated Approach to Testing and Assessment project. Feedback from regulators and other stakeholders was collected at several stages. Future chemical safety science projects can draw from this experience to implement systems toxicology-guided, animal-free next-generation risk assessment. Electronic supplementary material The online version of this article (10.1007/s00204-020-02866-4) contains supplementary material, which is available to authorized users.

[1]  Alexandra Maertens,et al.  Weighted Gene Correlation Network Analysis (WGCNA) Reveals Novel Transcription Factors Associated With Bisphenol A Dose-Response , 2018, Front. Genet..

[2]  Juan José Lozano,et al.  Generation of Hepatic Stellate Cells from Human Pluripotent Stem Cells Enables In Vitro Modeling of Liver Fibrosis. , 2018, Cell stem cell.

[3]  Angelo Moretto,et al.  Risk assessment in the 21st century: Roadmap and matrix , 2014, Critical reviews in toxicology.

[4]  Catherine Mahony,et al.  The SEURAT-1 approach towards animal free human safety assessment. , 2015, ALTEX.

[5]  Barry Hardy,et al.  Erratum to Template for the description of cell-based toxicological test methods to allow evaluation and regulatory use of the data. , 2020, ALTEX.

[6]  D. Krewski,et al.  Toxicity testing in the 21st century: progress in the past decade and future perspectives , 2019, Archives of Toxicology.

[7]  Wolfgang Moritz,et al.  Relevance of the incubation period in cytotoxicity testing with primary human hepatocytes , 2018, Archives of Toxicology.

[8]  Thomas Hartung,et al.  Food for thought ... on the evolution of toxicology and the phasing out of animal testing. , 2008, ALTEX.

[9]  Linda S Birnbaum,et al.  Informing 21st-Century Risk Assessments with 21st-Century Science , 2016, Environmental health perspectives.

[10]  Paul Jennings,et al.  Comparison of base-line and chemical-induced transcriptomic responses in HepaRG and RPTEC/TERT1 cells using TempO-Seq , 2018, Archives of Toxicology.

[11]  D. Ingber,et al.  Biology-Inspired Microphysiological Systems to Advance Patient Benefit and Animal Welfare in Drug Development , 2020, ALTEX.

[12]  W. Tong,et al.  Integrating adverse outcome pathways (AOPs) and high throughput in vitro assays for better risk evaluations, a study with drug-induced liver injury (DILI). , 2019, ALTEX.

[13]  S. H. Bennekou,et al.  Adverse outcome pathways: opportunities, limitations and open questions , 2017, Archives of Toxicology.

[14]  C. Gennings,et al.  The ENDpoiNTs Project: Novel Testing Strategies for Endocrine Disruptors Linked to Developmental Neurotoxicity , 2020, International journal of molecular sciences.

[15]  C. Rovida,et al.  Harnessing the power of novel animal-free test methods for the development of COVID-19 drugs and vaccines , 2020, Archives of Toxicology.

[16]  Bob van de Water,et al.  Dynamic imaging of adaptive stress response pathway activation for prediction of drug induced liver injury , 2018, Archives of Toxicology.

[17]  H. Volk,et al.  Tumor necrosis factor-induced apoptosis during the poisoning of mice with hepatotoxins. , 1997, Gastroenterology.

[18]  E. Evangelou,et al.  Literature review on epidemiological studies linking exposure to pesticides and health effects , 2013 .

[19]  Reinhard Kreiling,et al.  Principles underpinning the use of new methodologies in the risk assessment of cosmetic ingredients , 2018, Computational Toxicology.

[20]  Anton Simeonov,et al.  The US Federal Tox21 Program: A strategic and operational plan for continued leadership. , 2018, ALTEX.

[21]  Anna Forsby,et al.  Development of a neurotoxicity assay that is tuned to detect mitochondrial toxicants , 2019, Archives of Toxicology.

[22]  Sylvia Escher,et al.  Paradigm shift in safety assessment using new approach methods: The EU-ToxRisk strategy , 2019 .

[23]  B. van de Water,et al.  A screen for apoptotic synergism between clinical relevant nephrotoxicant and the cytokine TNF-α. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[24]  Paul Jennings,et al.  Application of three approaches for quantitative AOP development to renal toxicity , 2019, Computational Toxicology.

[25]  Emilio Benfenati,et al.  QSAR Modeling of ToxCast Assays Relevant to the Molecular Initiating Events of AOPs Leading to Hepatic Steatosis , 2018, J. Chem. Inf. Model..

[26]  Wolfgang Moritz,et al.  Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations , 2019, Archives of Toxicology.

[27]  Emilio Benfenati,et al.  A new semi-automated workflow for chemical data retrieval and quality checking for modeling applications , 2018, Journal of Cheminformatics.

[28]  Angelo Moretto,et al.  Illustrative case using the RISK21 roadmap and matrix: prioritization for evaluation of chemicals found in drinking water , 2015, Critical reviews in toxicology.

[29]  Chihae Yang,et al.  Novel technologies and an overall strategy to allow hazard assessment and risk prediction of chemicals, cosmetics, and drugs with animal-free methods. , 2012, ALTEX.

[30]  Paul Jennings,et al.  Differentiation of human iPSCs into functional podocytes , 2018, PloS one.

[31]  Emilio Benfenati,et al.  The application of new HARD-descriptor available from the CORAL software to building up NOAEL models. , 2017, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[32]  Andrey A Toropov,et al.  The index of ideality of correlation: A criterion of predictive potential of QSPR/QSAR models? , 2017, Mutation research.

[33]  Erik Lebret,et al.  Current EU research activities on combined exposure to multiple chemicals☆ , 2018, Environment international.

[34]  T. Hartung,et al.  Good Cell and Tissue Culture Practice 2.0 (GCCP 2.0) - Draft for stakeholder discussion and call for action. , 2020, ALTEX.

[35]  Raymond R Tice,et al.  FutureTox III: Bridges for Translation. , 2017, Toxicological sciences : an official journal of the Society of Toxicology.

[36]  B. van de Water,et al.  ATF6 Is a Critical Determinant of CHOP Dynamics during the Unfolded Protein Response , 2020, iScience.

[37]  Bob van de Water,et al.  System Microscopy of Stress Response Pathways in Cholestasis Research. , 2019, Methods in molecular biology.

[38]  U. Hofmann,et al.  Bile Microinfarcts in Cholestasis Are Initiated by Rupture of the Apical Hepatocyte Membrane and Cause Shunting of Bile to Sinusoidal Blood , 2018, Hepatology.

[39]  M. Berthold,et al.  Development of a neural rosette formation assay (RoFA) to identify neurodevelopmental toxicants and to characterize their transcriptome disturbances , 2019, Archives of Toxicology.

[40]  Gregory D. Tredwell,et al.  Persistence of Epigenomic Effects After Recovery From Repeated Treatment With Two Nephrocarcinogens , 2018, Front. Genet..

[41]  M. Britschgi,et al.  Incorporation of stem cell-derived astrocytes into neuronal organoids to allow neuro-glial interactions in toxicological studies. , 2020, ALTEX.

[42]  J. Hampe,et al.  The ascending pathophysiology of cholestatic liver disease , 2017, Hepatology.

[43]  Stem cell-derived models to improve mechanistic understanding and prediction of human drug-induced liver injury , 2017 .

[44]  Anton Simeonov,et al.  Good Cell Culture Practice for stem cells and stem-cell-derived models. , 2016, ALTEX.

[45]  M. Dellarco,et al.  A 21st century roadmap for human health risk assessment , 2014, Critical reviews in toxicology.

[46]  M. Pirmohamed,et al.  Human leukocyte antigen (HLA)‐B*57:01‐restricted activation of drug‐specific T cells provides the immunological basis for flucloxacillin‐induced liver injury , 2013, Hepatology.

[47]  R. Vadigepalli,et al.  Inflammation-associated suppression of metabolic gene networks in acute and chronic liver disease , 2020, Archives of Toxicology.

[48]  Yongxiang Fang,et al.  Characterisation of the NRF2 transcriptional network and its response to chemical insult in primary human hepatocytes: implications for prediction of drug-induced liver injury , 2018, Archives of Toxicology.

[49]  Xenia Dolde,et al.  A structure–activity relationship linking non-planar PCBs to functional deficits of neural crest cells: new roles for connexins , 2017, Archives of Toxicology.

[50]  Carsten Kneuer,et al.  Statement on advancing the assessment of chemical mixtures and their risks for human health and the environment , 2019, Environment international.

[51]  Barbara Zdrazil,et al.  Towards grouping concepts based on new approach methodologies in chemical hazard assessment: the read-across approach of the EU-ToxRisk project , 2019, Archives of Toxicology.

[52]  Thomas Hartung,et al.  Machine Learning of Toxicological Big Data Enables Read-Across Structure Activity Relationships (RASAR) Outperforming Animal Test Reproducibility , 2018, Toxicological sciences : an official journal of the Society of Toxicology.

[53]  K. Edlund,et al.  Road Map for Development of Stem Cell-Based Alternative Test Methods. , 2019, Trends in molecular medicine.

[54]  Thomas Hartung,et al.  The dawning of a new age of toxicology. , 2008, ALTEX.

[55]  B. Water,et al.  A systematic analysis of Nrf2 pathway activation dynamics during repeated xenobiotic exposure , 2018, Archives of Toxicology.

[56]  F. Troger,et al.  Using Machine Learning Methods and Structural Alerts for Prediction of Mitochondrial Toxicity , 2020, Molecular informatics.

[57]  Anna Forsby,et al.  In vitro acute and developmental neurotoxicity screening: an overview of cellular platforms and high-throughput technical possibilities , 2016, Archives of Toxicology.

[58]  Arthur P. Dempster,et al.  Upper and Lower Probabilities Induced by a Multivalued Mapping , 1967, Classic Works of the Dempster-Shafer Theory of Belief Functions.

[59]  Mardas Daneshian,et al.  Highlight report: Launch of a large integrated European in vitro toxicology project: EU-ToxRisk , 2016, Archives of Toxicology.

[60]  A. Dinnyés,et al.  Human Induced Pluripotent Stem Cell-Derived 3D-Neurospheres Are Suitable for Neurotoxicity Screening , 2020, Cells.

[61]  Thomas Hartung,et al.  Internationalization of Read-Across as a Validated New Approach Method (NAM) for Regulatory Toxicology , 2020, ALTEX.

[62]  E. Benfenati,et al.  QSAR Development for Plasma Protein Binding: Influence of the Ionization State , 2018, Pharmaceutical Research.

[63]  Alice Krebs,et al.  The EU-ToxRisk method documentation, data processing and chemical testing pipeline for the regulatory use of new approach methods , 2020, Archives of Toxicology.

[64]  Barry Hardy,et al.  Template for the description of cell-based toxicological test methods to allow evaluation and regulatory use of the data. , 2019, ALTEX.

[65]  Paul A. Schulte,et al.  The Next Generation of Risk Assessment Multi-Year Study—Highlights of Findings, Applications to Risk Assessment, and Future Directions , 2016, Environmental health perspectives.

[66]  M Jamei,et al.  VIVD: Virtual in vitro distribution model for the mechanistic prediction of intracellular concentrations of chemicals in in vitro toxicity assays. , 2019, Toxicology in vitro : an international journal published in association with BIBRA.

[67]  Thomas B Knudsen,et al.  Systems Toxicology , 2015, International journal of toxicology.

[68]  Mardas Daneshian,et al.  Consensus report on the future of animal-free systemic toxicity testing. , 2014, ALTEX.

[69]  S. H. Bennekou,et al.  An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition , 2017, Archives of Toxicology.

[70]  F. Bois,et al.  Development of a generic zebrafish embryo PBPK model and application to the developmental toxicity assessment of valproic acid analogs. , 2020, Reproductive toxicology.

[71]  Glenn Shafer,et al.  A Mathematical Theory of Evidence , 2020, A Mathematical Theory of Evidence.

[72]  Johanna R. McEntyre,et al.  The BioStudies database—one stop shop for all data supporting a life sciences study , 2017, Nucleic Acids Res..

[73]  Chihae Yang,et al.  Dempster-Shafer theory for combining in silico evidence and estimating uncertainty in chemical risk assessment , 2018 .

[74]  P. Carmeliet,et al.  Amino acid levels determine metabolism and CYP450 function of hepatocytes and hepatoma cell lines , 2020, Nature Communications.

[75]  C. Austin,et al.  Improving the Human Hazard Characterization of Chemicals: A Tox21 Update , 2013, Environmental health perspectives.

[76]  Mark T. D. Cronin,et al.  Assessing uncertainty in read-across: Questions to evaluate toxicity predictions based on knowledge gained from case studies , 2019, Computational Toxicology.

[77]  Giulia Callegaro,et al.  High-throughput confocal imaging of differentiated 3D liver-like spheroid cellular stress response reporters for identification of drug-induced liver injury liability , 2019, Archives of Toxicology.

[78]  Andrey A Toropov,et al.  The index of ideality of correlation: A criterion of predictability of QSAR models for skin permeability? , 2017, The Science of the total environment.

[79]  Bob van de Water,et al.  Diclofenac inhibits tumor necrosis factor‐α‐induced nuclear factor‐κB activation causing synergistic hepatocyte apoptosis , 2011, Hepatology.

[80]  Uwe Marx,et al.  Optimizing drug discovery by Investigative Toxicology: Current and future trends. , 2018, ALTEX.

[81]  C. Ribes-Koninckx,et al.  Direct conversion of human fibroblast to hepatocytes using a single inducible polycistronic vector , 2019, Stem cell research & therapy.

[82]  D. Krewski,et al.  A Framework for the Next Generation of Risk Science , 2014, Environmental health perspectives.

[83]  G. Ecker,et al.  Identification of mitochondrial toxicants by combined in silico and in vitro studies – A structure-based view on the adverse outcome pathway , 2020, Computational Toxicology.

[84]  U. Marx,et al.  Autologous induced pluripotent stem cell-derived four-organ-chip , 2019, Future science OA.

[85]  Alice Krebs,et al.  Determination of benchmark concentrations and their statistical uncertainty for cytotoxicity test data and functional in vitro assays. , 2019, ALTEX.

[86]  G. Groothuis,et al.  Drug-induced endoplasmic reticulum and oxidative stress responses independently sensitize toward TNFα-mediated hepatotoxicity. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[87]  J. Hengstler,et al.  Enhanced activation of human NK cells by drug-exposed hepatocytes , 2020, Archives of Toxicology.

[88]  Mardas Daneshian,et al.  Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicity. , 2018, ALTEX.

[89]  Thomas Hartung,et al.  Prediction of liver toxicity and mode of action using metabolomics in vitro in HepG2 cells , 2017, Archives of Toxicology.

[90]  A Worth,et al.  Next generation physiologically based kinetic (NG-PBK) models in support of regulatory decision making , 2019, Computational toxicology.

[91]  Ann M Richard,et al.  The Next Generation Blueprint of Computational Toxicology at the U.S. Environmental Protection Agency. , 2019, Toxicological sciences : an official journal of the Society of Toxicology.

[92]  Alice Krebs,et al.  Normalization of data for viability and relative cell function curves. , 2018, ALTEX.

[93]  R Daniel Benz,et al.  Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations , 2017, Environmental and molecular mutagenesis.

[94]  Alexandra Maertens,et al.  t4 report: Toward Good Read-Across Practice (GRAP) Guidance , 2016, ALTEX.

[95]  Emilio Benfenati,et al.  Integrating in silico models and read-across methods for predicting toxicity of chemicals: A step-wise strategy. , 2019, Environment international.

[96]  Marcus Groettrup,et al.  Prevention of neuronal apoptosis by astrocytes through thiol-mediated stress response modulation and accelerated recovery from proteotoxic stress , 2018, Cell Death & Differentiation.

[97]  M. Leist,et al.  Astrocyte Differentiation of Human Pluripotent Stem Cells: New Tools for Neurological Disorder Research , 2016, Front. Cell. Neurosci..